204 related articles for article (PubMed ID: 3143115)
21. Fluorescence HPLC methods for detecting benzo[a]pyrene-7,8-dihydrodiol 9,10-oxide-deoxyadenosine adducts in enzyme-digests of modified DNA: improved sensitivity.
Chen J; MacLeod MC; Zhao R; Geacintov NE
Carcinogenesis; 1993 May; 14(5):1049-51. PubMed ID: 8504464
[TBL] [Abstract][Full Text] [Related]
22. Benzo[a]pyrene-globin adducts detected by synchronous fluorescence spectrophotometry: method development and relation to lung DNA adducts in mice.
Bjelogrlic N; Vähäkangas K
Carcinogenesis; 1991 Dec; 12(12):2205-9. PubMed ID: 1747919
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence and mass spectral evidence for the formation of benzo[a]pyrene anti-diol-epoxide-DNA and -hemoglobin adducts in humans.
Weston A; Rowe ML; Manchester DK; Farmer PB; Mann DL; Harris CC
Carcinogenesis; 1989 Feb; 10(2):251-7. PubMed ID: 2912575
[TBL] [Abstract][Full Text] [Related]
24. Preparation, identification and analysis of stereoisomeric anti-benzo[a]pyrene diol epoxide-deoxyguanosine adducts using phenyl liquid chromatography with diode array, fluorescence and tandem mass spectrometry detection.
Feng F; Yin J; Song M; Wang H
J Chromatogr A; 2008 Mar; 1183(1-2):119-28. PubMed ID: 18243229
[TBL] [Abstract][Full Text] [Related]
25. Solid matrix, room temperature phosphorescence identification and quantitation of the tetrahydrotetrols derived from the acid hydrolysis of benzo[a]pyrene-DNA adducts from human lung.
Corley J; Hurtubise RJ; Bowman ED; Weston A
Carcinogenesis; 1995 Feb; 16(2):423-6. PubMed ID: 7859376
[TBL] [Abstract][Full Text] [Related]
26. Fluorescence spectral evidence that benzo[a]pyrene is activated by metabolism in mouse skin to a diol-epoxide and a phenol-epoxide.
Vigny P; Ginot YM; Kindts M; Cooper CS; Grover PL; Sims P
Carcinogenesis; 1980; 1(11):945-50. PubMed ID: 11219848
[TBL] [Abstract][Full Text] [Related]
27. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes.
Shields PG; Bowman ED; Harrington AM; Doan VT; Weston A
Cancer Res; 1993 Aug; 53(15):3486-92. PubMed ID: 8339251
[TBL] [Abstract][Full Text] [Related]
28. A rapid method for isolation of human hemoglobin benzo[a]pyrene diol epoxide derived adducts using high performance liquid chromatography.
Naylor S; Gan LS; Day BW; Skipper PL; Tannenbaum SR
Biomed Chromatogr; 1989 Nov; 3(6):266-8. PubMed ID: 2515899
[TBL] [Abstract][Full Text] [Related]
29. Immunocytochemical localization of benzo(a)pyrene-DNA adducts in human tissue.
Shamsuddin AK; Gan R
Hum Pathol; 1988 Mar; 19(3):309-15. PubMed ID: 3126127
[TBL] [Abstract][Full Text] [Related]
30. The relationship between benzo(a)pyrene diol-epoxide-DNA adducts and mutagenicity in the CHO/HPGRT assay.
Recio L; Shugart LR; Hsie AW
Fundam Appl Toxicol; 1987 Feb; 8(2):243-52. PubMed ID: 3104121
[TBL] [Abstract][Full Text] [Related]
31. Preferential modification of GC boxes by benzo[a]pyrene-7,8-diol-9,10-epoxide.
Kootstra A; Lew LK; Nairn RS; MacLeod MC
Mol Carcinog; 1989; 1(4):239-44. PubMed ID: 2506885
[TBL] [Abstract][Full Text] [Related]
32. Mass spectrometric sequencing of site-specific carcinogen-modified oligodeoxyribonucleotides containing bulky benzo[a]pyrene diol epoxide-deoxyguanosyl adducts.
Ni J; Liu T; Kolbanovskiy A; Krzeminski J; Amin S; Geacintov NE
Anal Biochem; 1998 Nov; 264(2):222-9. PubMed ID: 9866687
[TBL] [Abstract][Full Text] [Related]
33. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
Ginsberg GL; Atherholt TB
Cancer Res; 1990 Feb; 50(4):1189-94. PubMed ID: 2105163
[TBL] [Abstract][Full Text] [Related]
34. Evidence for substantial formation of r-7,t-8-dihydroxy-c-9,10-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene- deoxyguanosine in human lymphocytes treated in vitro with benzo[a]pyrene.
Pavanello S; Rojas M; Paleologo M; Levis AG; Alexandrov K
Carcinogenesis; 1989 May; 10(5):945-7. PubMed ID: 2495866
[TBL] [Abstract][Full Text] [Related]
35. Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods.
Boysen G; Hecht SS
Mutat Res; 2003 Jan; 543(1):17-30. PubMed ID: 12510015
[TBL] [Abstract][Full Text] [Related]
36. Conformations and selective photodissociation of heterogeneous benzo(a)pyrene diol epoxide enantiomer-DNA adducts.
Zinger D; Geacintov NE; Harvey RG
Biophys Chem; 1987 Aug; 27(2):131-8. PubMed ID: 3117127
[TBL] [Abstract][Full Text] [Related]
37. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
Dreij K; Seidel A; Jernström B
Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
[TBL] [Abstract][Full Text] [Related]
38. Tetrahydroxylated-benzo[a]pyrene isomer analysis after hydrolysis of DNA-adducts isolated from rat and human white blood cells.
Grova N; Salquèbre G; Hardy EM; Schroeder H; Appenzeller BM
J Chromatogr A; 2014 Oct; 1364():183-91. PubMed ID: 25239702
[TBL] [Abstract][Full Text] [Related]
39. Fluorescence measurements of DNA-bound metabolites of benzo(a)pyrene derivatives with different carcinogenic effects.
Gräslund A; Jernström B; Undeman O; Dock L; Ehrenberg A; Astlind T
Toxicol Pathol; 1984; 12(2):179-84. PubMed ID: 11478320
[TBL] [Abstract][Full Text] [Related]
40. Dosimeters of human exposure to carcinogens: polycyclic aromatic hydrocarbon-macromolecular adducts.
Weston A; Willey JC; Manchester DK; Wilson VL; Brooks BR; Choi JS; Poirier MC; Trivers GE; Newman MJ; Mann DL
IARC Sci Publ; 1988; (89):181-9. PubMed ID: 3143667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
